Voyager Therapeutics, Inc. Depreciation
Voyager Therapeutics, Inc. (VYGR) reported Depreciation of $1.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Voyager Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $908.00K, a 14.74% decline year-over-year.
- Voyager Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $932.00K, a 8.09% decline year-over-year.
- Voyager Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $1.05M, a 3.76% increase year-over-year.
- Voyager Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $932.00K, a 17.67% decline year-over-year.
- Voyager Therapeutics, Inc. depreciation for fiscal 2025 was $4.06M, a 14.18% decline from fiscal 2024.
- Voyager Therapeutics, Inc. depreciation for fiscal 2024 was $4.73M, a 6.53% increase from fiscal 2023.
- Voyager Therapeutics, Inc. depreciation for fiscal 2023 was $4.44M, a 28.27% decline from fiscal 2022.
- Voyager Therapeutics, Inc. depreciation for fiscal 2022 was $6.19M, a 19.86% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $908.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.84M 10-Q · filed 2026-08-06 | $2.89M derived: sum of 3 quarters · filed 2026-08-06 | $3.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $932.00K 10-Q · filed 2026-05-07 | $1.98M derived: sum of 2 quarters · filed 2026-05-07 | $2.91M derived: sum of 3 quarters · filed 2026-05-07 | $3.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.98M derived: sum of 2 quarters · filed 2026-03-09 | $3.05M derived: sum of 3 quarters · filed 2026-08-06 | $4.06M 10-K · filed 2026-03-09 |
| 2025-09-30 | $932.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.00M derived: sum of 2 quarters · filed 2026-08-06 | $3.01M 10-Q · filed 2025-11-10 | $4.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.08M 10-Q · filed 2026-08-06 | $3.09M derived: sum of 3 quarters · filed 2026-08-06 | $4.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.01M 10-Q · filed 2026-05-07 | $2.02M derived: sum of 2 quarters · filed 2026-05-07 | $3.16M derived: sum of 3 quarters · filed 2026-05-07 | $4.55M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.14M derived: sum of 2 quarters · filed 2026-03-09 | $3.54M derived: sum of 3 quarters · filed 2026-03-09 | $4.73M 10-K · filed 2026-03-09 |
| 2024-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.52M derived: sum of 2 quarters · filed 2025-11-10 | $3.72M 10-Q · filed 2025-11-10 | $5.05M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.59M 10-Q · filed 2025-08-06 | $3.92M derived: sum of 3 quarters · filed 2026-03-09 | $4.87M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $1.20M 10-Q · filed 2025-05-06 | $2.53M derived: sum of 2 quarters · filed 2026-03-09 | $3.48M derived: sum of 3 quarters · filed 2026-03-09 | $4.56M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.28M derived: sum of 2 quarters · filed 2026-03-09 | $3.37M derived: sum of 3 quarters · filed 2026-03-09 | $4.44M 10-K · filed 2026-03-09 |
| 2023-09-30 | $945.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.03M derived: sum of 2 quarters · filed 2024-11-12 | $3.11M 10-Q · filed 2024-11-12 | $3.94M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.16M 10-Q · filed 2024-08-06 | $3.00M derived: sum of 3 quarters · filed 2025-03-11 | $4.34M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $1.07M 10-Q · filed 2024-05-13 | $1.91M derived: sum of 2 quarters · filed 2025-03-11 | $3.25M derived: sum of 3 quarters · filed 2025-03-11 | $4.45M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $834.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.17M derived: sum of 2 quarters · filed 2025-03-11 | $3.38M derived: sum of 3 quarters · filed 2025-03-11 | $6.19M 10-K · filed 2025-03-11 |
| 2022-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $2.54M derived: sum of 2 quarters · filed 2023-11-06 | $5.36M 10-Q · filed 2023-11-06 | $6.84M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.02M 10-Q · filed 2023-08-03 | $5.50M derived: sum of 3 quarters · filed 2024-02-28 | $6.72M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.81M 10-Q · filed 2023-05-09 | $4.29M derived: sum of 2 quarters · filed 2024-02-28 | $5.52M derived: sum of 3 quarters · filed 2024-02-28 | $6.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.71M derived: sum of 2 quarters · filed 2024-02-28 | $3.89M derived: sum of 3 quarters · filed 2024-02-28 | $5.17M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.41M derived: sum of 2 quarters · filed 2022-11-08 | $3.68M 10-Q · filed 2022-11-08 | $4.67M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.46M 10-Q · filed 2022-08-04 | $3.45M derived: sum of 3 quarters · filed 2023-03-07 | $4.51M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $1.27M 10-Q · filed 2022-05-04 | $2.26M derived: sum of 2 quarters · filed 2023-03-07 | $3.32M derived: sum of 3 quarters · filed 2023-03-07 | $4.25M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $987.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $2.05M derived: sum of 2 quarters · filed 2023-03-07 | $2.98M derived: sum of 3 quarters · filed 2023-03-07 | $3.82M 10-K · filed 2023-03-07 |
| 2020-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.99M derived: sum of 2 quarters · filed 2021-11-02 | $2.83M 10-Q · filed 2021-11-02 | $3.59M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $926.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.77M 10-Q · filed 2021-08-09 | $2.53M derived: sum of 3 quarters · filed 2022-03-08 | $3.24M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $842.00K 10-Q · filed 2021-05-10 | $1.60M derived: sum of 2 quarters · filed 2022-03-08 | $2.31M derived: sum of 3 quarters · filed 2022-03-08 | $2.99M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.47M derived: sum of 2 quarters · filed 2022-03-08 | $2.15M derived: sum of 3 quarters · filed 2022-03-08 | $2.77M 10-K · filed 2022-03-08 |
| 2019-09-30 | $715.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.39M derived: sum of 2 quarters · filed 2020-11-09 | $2.01M 10-Q · filed 2020-11-09 | $2.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.29M 10-Q · filed 2020-08-10 | $1.87M derived: sum of 3 quarters · filed 2021-02-25 | $2.44M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $616.00K 10-Q · filed 2020-05-06 | $1.20M derived: sum of 2 quarters · filed 2021-02-25 | $1.76M derived: sum of 3 quarters · filed 2021-02-25 | $2.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.15M derived: sum of 2 quarters · filed 2021-02-25 | $1.66M derived: sum of 3 quarters · filed 2021-02-25 | $2.12M 10-K · filed 2021-02-25 |
| 2018-09-30 | $566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.08M derived: sum of 2 quarters · filed 2019-11-06 | $1.54M 10-Q · filed 2019-11-06 | $1.97M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $972.00K 10-Q · filed 2019-08-09 | $1.41M derived: sum of 3 quarters · filed 2020-03-03 | $1.84M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $456.00K 10-Q · filed 2019-05-07 | $892.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.32M derived: sum of 3 quarters · filed 2020-03-03 | $1.73M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $869.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.28M derived: sum of 3 quarters · filed 2020-03-03 | $1.59M 10-K · filed 2020-03-03 |
| 2017-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $842.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.16M 10-Q · filed 2018-11-07 | $1.32M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $409.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $726.00K 10-Q · filed 2018-08-07 | $890.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.05M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $317.00K 10-Q · filed 2018-05-10 | $481.00K derived: sum of 2 quarters · filed 2019-02-26 | $641.00K derived: sum of 3 quarters · filed 2019-02-26 | $793.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $324.00K derived: sum of 2 quarters · filed 2019-02-26 | $476.00K derived: sum of 3 quarters · filed 2019-02-26 | $612.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $312.00K derived: sum of 2 quarters · filed 2017-11-02 | $448.00K 10-Q · filed 2017-11-02 | $612.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $288.00K 10-Q · filed 2017-08-08 | $452.00K derived: sum of 3 quarters · filed 2018-03-14 | $515.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $136.00K 10-Q · filed 2017-05-09 | $300.00K derived: sum of 2 quarters · filed 2018-03-14 | $363.00K derived: sum of 3 quarters · filed 2018-03-14 | $508.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $227.00K derived: sum of 2 quarters · filed 2018-03-14 | $372.00K derived: sum of 3 quarters · filed 2018-03-14 | $600.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | $63.00K 10-Q · filed 2015-12-17 | $208.00K derived: sum of 2 quarters · filed 2016-08-11 | $436.00K 10-Q · filed 2016-11-10 | $450.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $276.00K 10-Q · filed 2016-08-11 | $387.00K derived: sum of 3 quarters · filed 2017-03-15 | $547.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $131.00K 10-Q · filed 2016-05-12 | $242.00K derived: sum of 2 quarters · filed 2017-03-15 | $402.00K derived: sum of 3 quarters · filed 2017-03-15 | |
| 2014-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $271.00K derived: sum of 2 quarters · filed 2017-03-15 | $184.00K 10-K · filed 2017-03-15 | |
| 2014-09-30 | $160.00K 10-Q · filed 2015-12-17 | $73.00K 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |